Retrospective Studies

Lophatananon, A., Carr, M., McMillan, B., Dobson, C., Itzhaki, R., Parisi, R., et al. (2023). The association of herpes zoster and influenza vaccinations with the risk of developing dementia: a population-based cohort study within the UK Clinical Practice Research Datalink. Bmc Public Health, 23, 1903. http://doi.org/10.1186/s12889-023-16768-4
View
Schene, M. R., Wyers, C. E., Driessen, A. M. H., Souverein, P. C., Gemmeke, M., van den Bergh, J. P., & Willems, H. C. (2023). Imminent fall risk after fracture. Age Ageing, 52. http://doi.org/10.1093/ageing/afad201
View
Andresen, K., Carreira, H., Strongman, H., McDonald, H. I., Benitez-Majano, S., Mansfield, K. E., et al. (2023). The risk of acute kidney injury in colorectal cancer survivors: an english population-based matched cohort study. Bmc Cancer, 23, 839. http://doi.org/10.1186/s12885-023-11329-9
View
Requena, G., Czira, A., Banks, V., Wood, R., Tritton, T., Castillo, C., et al. (2023). Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England. Int J Chron Obstruct Pulmon Dis, 18, 2039-2054. http://doi.org/10.2147/copd.s408688
View
Ismaila, A. S., Rothnie, K. J., Wood, R. P., Banks, V. L., Camidge, L. J., Czira, A., et al. (2023). Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study. Respir Res, 24, 229. http://doi.org/10.1186/s12931-023-02523-1
View
Qizilbash, N., Kataria, H., Jarman, H., Bloom, B., Bradney, M., Oh, M., et al. (2023). Real world safety of methoxyflurane analgesia in the emergency setting: a comparative hybrid prospective-retrospective post-authorisation safety study. Bmc Emerg Med, 23, 100. http://doi.org/10.1186/s12873-023-00862-2
View
Pollock, C., Sanchez, J. J. G., Carrero, J. J., Kumar, S., Pecoits-Filho, R., Lam, C. S. P., et al. (2023). Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification. Diabet Med, e15200. http://doi.org/10.1111/dme.15200
View
Douros, A., Lix, L. M., Fralick, M., Dell'Aniello, S., Shah, B. R., Ronksley, P. E., et al. (2020). Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study. Ann Intern Med, 173, 417-425. http://doi.org/10.7326/m20-0289
View
Harris, J., Pouwels, K. B., Johnson, T., Sterne, J., Pithara, C., Mahadevan, K., et al. (2023). Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies. Health Technol Assess, 27, 1-257. http://doi.org/10.3310/mnjy9014
View
Requena, G., Czira, A., Banks, V., Wood, R., Tritton, T., Castillo, C. M., et al. (2023). Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. Int J Chron Obstruct Pulmon Dis, 18, 1431-1444. http://doi.org/10.2147/copd.s411437
View